These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38947288)

  • 1. Histopathological impact of SARS-CoV-2 on the liver: Cellular damage and long-term complications.
    Rodriguez-Espada A; Salgado-de la Mora M; Rodriguez-Paniagua BM; Limon-de la Rosa N; Martinez-Gutierrez MI; Pastrana-Brandes S; Navarro-Alvarez N
    World J Gastroenterol; 2024 Jun; 30(22):2866-2880. PubMed ID: 38947288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
    Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
    J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation Between Clinical and Pathological Findings of Liver Injury in 27 Patients With Lethal COVID-19 Infections in Brazil.
    Santana MF; Guerra MT; Hundt MA; Ciarleglio MM; Pinto RAA; Dutra BG; Xavier MS; Lacerda MVG; Ferreira AJ; Wanderley DC; Borges do Nascimento IJ; Araújo RFA; Pinheiro SVB; Araújo SA; Leite MF; Ferreira LCL; Nathanson MH; Vieira Teixeira Vidigal P
    Hepatol Commun; 2022 Feb; 6(2):270-280. PubMed ID: 34520633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-based SARS-CoV-2 detection in fatal COVID-19 infections: Sustained direct viral-induced damage is not necessary to drive disease progression.
    El Jamal SM; Pujadas E; Ramos I; Bryce C; Grimes ZM; Amanat F; Tsankova NM; Mussa Z; Olson S; Salem F; Miorin L; Aydillo T; Schotsaert M; Albrecht RA; Liu WC; Marjanovic N; Francoeur N; Sebra R; Sealfon SC; García-Sastre A; Fowkes M; Cordon-Cardo C; Westra WH
    Hum Pathol; 2021 Aug; 114():110-119. PubMed ID: 33961839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiological mechanisms of liver injury in COVID-19.
    Nardo AD; Schneeweiss-Gleixner M; Bakail M; Dixon ED; Lax SF; Trauner M
    Liver Int; 2021 Jan; 41(1):20-32. PubMed ID: 33190346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic complications of COVID-19 and its treatment.
    Tian D; Ye Q
    J Med Virol; 2020 Oct; 92(10):1818-1824. PubMed ID: 32437004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Liver in COVID-19-Related Death: Protagonist or Innocent Bystander?
    Schmit G; Lelotte J; Vanhaebost J; Horsmans Y; Van Bockstal M; Baldin P
    Pathobiology; 2021; 88(1):88-94. PubMed ID: 33108789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver.
    Lei HY; Ding YH; Nie K; Dong YM; Xu JH; Yang ML; Liu MQ; Wei L; Nasser MI; Xu LY; Zhu P; Zhao MY
    Biomed Pharmacother; 2021 Jan; 133():111064. PubMed ID: 33378966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling the Molecular and Cellular Pathogenesis of COVID-19-Associated Liver Injury.
    Akkiz H
    Viruses; 2023 May; 15(6):. PubMed ID: 37376587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological findings in the postmortem liver of patients with coronavirus disease 2019 (COVID-19).
    Zhao CL; Rapkiewicz A; Maghsoodi-Deerwester M; Gupta M; Cao W; Palaia T; Zhou J; Ram B; Vo D; Rafiee B; Hossein-Zadeh Z; Dabiri B; Hanna I
    Hum Pathol; 2021 Mar; 109():59-68. PubMed ID: 33307078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management.
    Xu Y; Yang X; Bian H; Xia M
    Lipids Health Dis; 2021 Oct; 20(1):126. PubMed ID: 34602072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE2: from protection of liver disease to propagation of COVID-19.
    Warner FJ; Rajapaksha H; Shackel N; Herath CB
    Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients.
    Lizardo-Thiebaud MJ; Cervantes-Alvarez E; Limon-de la Rosa N; Tejeda-Dominguez F; Palacios-Jimenez M; Méndez-Guerrero O; Delaye-Martinez M; Rodriguez-Alvarez F; Romero-Morales B; Liu WH; Huang CA; Kershenobich D; Navarro-Alvarez N
    Semin Liver Dis; 2020 Aug; 40(3):321-330. PubMed ID: 32886936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver histopathology in COVID-19 patients: A mono-Institutional series of liver biopsies and autopsy specimens.
    Fassan M; Mescoli C; Sbaraglia M; Guzzardo V; Russo FP; Fabris R; Trevenzoli M; Pelizzaro F; Cattelan AM; Basso C; Navalesi P; Farinati F; Vettor R; Dei Tos AP
    Pathol Res Pract; 2021 May; 221():153451. PubMed ID: 33932720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case-control autopsy series of liver pathology associated with novel coronavirus disease (COVID-19).
    Righi FA; Vander Heide RS; Graham RP; Aubry MC; Trejo-Lopez JA; Bois MC; Roden AC; Reichard R; Maleszewski JJ; Alexander MP; Quinton RA; Jenkins SM; Hartley CP; Hagen CE
    Ann Diagn Pathol; 2024 Feb; 68():152240. PubMed ID: 37995413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic Changes of the Blood Chemistry in Syrian Hamsters Post-Acute COVID-19.
    Hsu CJ; Lin WC; Chou YC; Yang CM; Wu HL; Cheng YH; Liu PC; Chang JY; Chen HY; Sun JR
    Microbiol Spectr; 2022 Feb; 10(1):e0236221. PubMed ID: 35196799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and cellular mechanisms of liver dysfunction in COVID-19.
    Huang C; Li Q; Xu W; Chen L
    Discov Med; 2020; 30(160):107-112. PubMed ID: 33382966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
    Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
    J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 induced liver injury: Incidence, risk factors, impact on COVID-19 severity and prognosis in different population groups.
    Liatsos GD
    World J Gastroenterol; 2023 Apr; 29(16):2397-2432. PubMed ID: 37179584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms underlying SARS-CoV-2 hepatotropism and liver damage.
    Quarleri J; Delpino MV
    World J Hepatol; 2024 Jan; 16(1):1-11. PubMed ID: 38313242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.